{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:27:25Z","timestamp":1792114045624,"version":"4.4.0"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.redox.2024.103457","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T17:19:30Z","timestamp":1733419170000},"page":"103457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["HDAC6 inhibitor-loaded brain-targeted nanocarrier-mediated neuroprotection in methamphetamine-driven Parkinson's disease"],"prefix":"10.1016","volume":"79","author":[{"given":"Khang-Yen","family":"Pham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shristi","family":"Khanal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh","family":"Bohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikesh","family":"Rimal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Hoon","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thoa Thi Kim","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In-Sun","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinkyung","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Sun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sooyeun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Young","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2129-1890","authenticated-orcid":false,"given":"Simmyung","family":"Yook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.redox.2024.103457_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2021.101328","article-title":"Nanomaterials as novel agents for amelioration of Parkinson's disease","volume":"41","author":"Wu","year":"2021","journal-title":"Nano Today"},{"key":"10.1016\/j.redox.2024.103457_bib2","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"V Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.redox.2024.103457_bib3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s40820-022-00847-z","article-title":"Anti-Parkinsonian therapy: strategies for crossing the blood\u2013brain barrier and nano-biological effects of nanomaterials","volume":"14","author":"Cheng","year":"2022","journal-title":"Nano-Micro Lett."},{"key":"10.1016\/j.redox.2024.103457_bib4","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1021\/acsnano.9b06453","article-title":"A self-assembled \u03b1-synuclein nanoscavenger for Parkinson's disease","volume":"14","author":"Liu","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.redox.2024.103457_bib5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","article-title":"The pathogenesis of Parkinson's disease","volume":"403","author":"Morris","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.redox.2024.103457_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202105152","article-title":"Treating LRRK2-related Parkinson's disease by inhibiting the mTOR signaling pathway to restore autophagy","volume":"31","author":"Cui","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.redox.2024.103457_bib7","doi-asserted-by":"crossref","first-page":"19961","DOI":"10.1021\/acsnano.3c05011","article-title":"Engineered selenium\/human serum albumin nanoparticles for efficient targeted treatment of Parkinson's disease via oral gavage","volume":"17","author":"Xu","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.redox.2024.103457_bib8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1474-4422(18)30081-4","article-title":"Accelerating research for Parkinson's disease","volume":"17","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.redox.2024.103457_bib9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2169\/internalmedicine.8940-21","article-title":"Recent advances in drug therapy for Parkinson disease","volume":"62","author":"Murakami","year":"2023","journal-title":"Intern. Med."},{"key":"10.1016\/j.redox.2024.103457_bib10","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and treatment of Parkinson disease: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.redox.2024.103457_bib11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3233\/JPD-225060","article-title":"Pharmacological treatment of tremor in Parkinson's disease revisited","volume":"13","author":"Pirker","year":"2023","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.redox.2024.103457_bib12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41531-021-00179-6","article-title":"Synucleinopathy-associated pathogenesis in Parkinson's disease and the potential for brain-derived neurotrophic factor","volume":"7","author":"Miller","year":"2021","journal-title":"Npj Park. Dis."},{"key":"10.1016\/j.redox.2024.103457_bib13","article-title":"Engineered exosomes with independent module\/cascading function for therapy of Parkinson's disease by multistep targeting and multistage intervention method","volume":"34","author":"Wang","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.redox.2024.103457_bib14","doi-asserted-by":"crossref","first-page":"21730","DOI":"10.1021\/jacs.0c09390","article-title":"Targeting microglia for therapy of Parkinson's disease by using biomimetic ultrasmall nanoparticles","volume":"142","author":"Liu","year":"2020","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.redox.2024.103457_bib15","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1021\/acsnano.1c08473","article-title":"Intranasal administration of self-oriented nanocarriers based on therapeutic exosomes for synergistic treatment of Parkinson's disease","volume":"16","author":"Peng","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.redox.2024.103457_bib16","article-title":"Controlled activation of TRPV1 channels on microglia to boost their autophagy for clearance of alpha-synuclein and enhance therapy of Parkinson's disease","volume":"34","author":"Yuan","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.redox.2024.103457_bib17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1021\/acschemneuro.8b00180","article-title":"Novel targets for Parkinson's disease: addressing different therapeutic paradigms and conundrums","volume":"10","author":"Rane","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.redox.2024.103457_bib18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3233\/JPD-202221","article-title":"Treating Parkinson's disease with antibodies: previous studies and future directions","volume":"11","author":"Castonguay","year":"2021","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.redox.2024.103457_bib19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13024-023-00600-z","article-title":"Translational molecular imaging and drug development in Parkinson's disease","volume":"18","author":"Haider","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.redox.2024.103457_bib20","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1474-4422(21)00061-2","article-title":"Progress towards therapies for disease modification in Parkinson's disease","volume":"20","author":"Vijiaratnam","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.redox.2024.103457_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2023.141606","article-title":"Stimulus-responsive curcumin-based polydopamine nanoparticles for targeting Parkinson's disease by modulating \u03b1-synuclein aggregation and reactive oxygen species","volume":"461","author":"Lei","year":"2023","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.redox.2024.103457_bib22","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nrn3549","article-title":"Parkinson's disease dementia: convergence of \u03b1-synuclein, tau and amyloid-\u03b2 pathologies","volume":"14","author":"Irwin","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.redox.2024.103457_bib23","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jconrel.2024.03.010","article-title":"Focused ultrasound-mediated cerium-based nanoreactor against Parkinson's disease via ROS regulation and microglia polarization","volume":"368","author":"Gao","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.redox.2024.103457_bib24","article-title":"A Dual synergetic nanoreactor for managing Parkinson's disease by regulating inflammation and mitigating oxidative damage","volume":"33","author":"Li","year":"2023","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.redox.2024.103457_bib25","doi-asserted-by":"crossref","first-page":"7511","DOI":"10.1021\/acsnano.2c12614","article-title":"Single-atom nanocatalytic therapy for suppression of neuroinflammation by inducing autophagy of abnormal mitochondria","volume":"17","author":"Li","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.redox.2024.103457_bib26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12013-022-01125-w","article-title":"Advances in the mechanistic study of the control of oxidative stress injury by modulating HDAC6 activity","volume":"81","author":"Xue","year":"2023","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.redox.2024.103457_bib27","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/TA.0000000000000784","article-title":"Selective inhibition of histone deacetylase 6 promotes survival in a rat model of hemorrhagic shock","volume":"79","author":"Chang","year":"2015","journal-title":"J. Trauma Acute Care Surg."},{"key":"10.1016\/j.redox.2024.103457_bib28","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1021\/acs.jmedchem.0c01782","article-title":"A Review of progress in histone deacetylase 6 inhibitors research: structural specificity and functional diversity","volume":"64","author":"Zhang","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.redox.2024.103457_bib29","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/nm.2396","article-title":"HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth disease","volume":"17","author":"d'Ydewalle","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.redox.2024.103457_bib30","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/sj.cdd.4401769","article-title":"HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis","volume":"13","author":"Saha","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.redox.2024.103457_bib31","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41531-023-00607-9","article-title":"Linking acetylated \u03b1-tubulin redistribution to \u03b1-synuclein pathology in brain of Parkinson's disease patients","volume":"10","author":"Mazzetti","year":"2024","journal-title":"Npj Park. Dis"},{"key":"10.1016\/j.redox.2024.103457_bib32","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/nrd2681","article-title":"Therapeutic application of histone deacetylase inhibitors for central nervous system disorders","volume":"7","author":"Kazantsev","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.redox.2024.103457_bib33","article-title":"Recent advances in small molecular modulators targeting histone deacetylase 6, Futur","volume":"2","author":"Xiao","year":"2020","journal-title":"Drug Discov."},{"key":"10.1016\/j.redox.2024.103457_bib34","article-title":"HDAC6 regulates mitochondrial transport in hippocampal neurons","volume":"5","author":"Chen","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.redox.2024.103457_bib35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1021\/acs.jmedchem.9b00924","article-title":"Old but Gold: tracking the new guise of histone deacetylase 6 (HDAC6) enzyme as a biomarker and therapeutic target in rare diseases","volume":"63","author":"Brindisi","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.redox.2024.103457_bib36","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1523\/JNEUROSCI.0037-07.2007","article-title":"Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation","volume":"27","author":"Dompierre","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.redox.2024.103457_bib37","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1021\/acschemneuro.9b00338","article-title":"Novel HDAC6 inhibitors increase tubulin acetylation and rescue axonal transport of mitochondria in a model of Charcot\u2013Marie\u2013Tooth Type 2F","volume":"11","author":"Adalbert","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.redox.2024.103457_bib38","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40035-023-00354-0","article-title":"Microtubule acetylation dyshomeostasis in Parkinson's disease","volume":"12","author":"Naren","year":"2023","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.redox.2024.103457_bib39","article-title":"An HDAC6 inhibitor, alleviates stroke-induced brain infarction and functional deficits: potential roles of \u03b1-tubulin acetylation and FGF-21 up-regulation","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.redox.2024.103457_bib40","article-title":"HDAC6 inhibitor blocks amyloid beta-induced impairment of mitochondrial transport in hippocampal neurons","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.redox.2024.103457_bib41","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202401145","article-title":"Presynaptic perspective: axonal transport defects in neurodevelopmental disorders","volume":"223","author":"Xiong","year":"2024","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.redox.2024.103457_bib42","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1111\/bph.13208","article-title":"Neurorestoration induced by the HDAC inhibitor sodium valproate in the lactacystin model of Parkinson's is associated with histone acetylation and up-regulation of neurotrophic factors","volume":"172","author":"Harrison","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.redox.2024.103457_bib43","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/jnc.14599","article-title":"The histone deacetylase inhibitor nicotinamide exacerbates neurodegeneration in the lactacystin rat model of Parkinson's disease","volume":"148","author":"Harrison","year":"2019","journal-title":"J. Neurochem."},{"key":"10.1016\/j.redox.2024.103457_bib44","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.bbr.2015.05.052","article-title":"Beneficial effects of sodium butyrate in 6-OHDA induced neurotoxicity and behavioral abnormalities: modulation of histone deacetylase activity","volume":"291","author":"Sharma","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.redox.2024.103457_bib45","article-title":"Acetylation of NDUFV1 induced by a newly synthesized HDAC6 inhibitor HGC rescues dopaminergic neuron loss in Parkinson models","volume":"24","author":"Li","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.redox.2024.103457_bib46","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12931-024-02688-3","article-title":"HDAC6-selective inhibitor CAY10603 ameliorates cigarette smoke-induced small airway remodeling by regulating epithelial barrier dysfunction and reversing","volume":"25","author":"Zhang","year":"2024","journal-title":"Respir. Res."},{"key":"10.1016\/j.redox.2024.103457_bib47","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/jnc.14849","article-title":"Histone deacetylase 6 promotes growth of glioblastoma through the MKK7\/JNK\/c-Jun signaling pathway","volume":"152","author":"Huang","year":"2020","journal-title":"J. Neurochem."},{"key":"10.1016\/j.redox.2024.103457_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.938391","article-title":"Inhibition of HDAC6 with CAY10603 ameliorates diabetic kidney disease by suppressing NLRP3 inflammasome","volume":"13","author":"Hou","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.redox.2024.103457_bib49","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1158\/1535-7163.MCT-14-0481","article-title":"Histone deacetylase 6 represents a novel drug target in the oncogenic hedgehog signaling pathway","volume":"14","author":"Dhanyamraju","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.redox.2024.103457_bib50","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1021\/acsnano.3c10674","article-title":"Functionalized nanomaterials capable of crossing the blood\u2013brain barrier","volume":"18","author":"Zha","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.redox.2024.103457_bib51","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1021\/acs.molpharmaceut.2c00811","article-title":"Recent advancements in the design of nanodelivery systems of siRNA for cancer therapy","volume":"19","author":"Yadav","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.redox.2024.103457_bib52","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/s41551-021-00698-w","article-title":"The evolution of commercial drug delivery technologies","volume":"5","author":"Vargason","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.redox.2024.103457_bib53","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s40005-021-00548-6","article-title":"Multifunctional lipidic nanocarriers for effective therapy of glioblastoma: recent advances in stimuli-responsive, receptor and subcellular targeted approaches","volume":"52","author":"Hegde","year":"2022","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.redox.2024.103457_bib54","doi-asserted-by":"crossref","first-page":"6602","DOI":"10.1038\/s41598-017-06888-4","article-title":"Overcoming blood brain barrier with a dual purpose temozolomide loaded lactoferrin nanoparticles for combating glioma","volume":"7","author":"Kumari","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.redox.2024.103457_bib55","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","article-title":"PLGA-based nanoparticles: an overview of biomedical applications","volume":"161","author":"Danhier","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.redox.2024.103457_bib56","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s40204-015-0037-z","article-title":"Assessment of lactoferrin-conjugated solid lipid nanoparticles for efficient targeting to the lung","volume":"4","author":"Shilpi","year":"2015","journal-title":"Prog. Biomater."},{"key":"10.1016\/j.redox.2024.103457_bib57","article-title":"Brain-targeted liposomes loaded with monoclonal antibodies reduce alpha-synuclein aggregation and improve behavioral symptoms in Parkinson's disease","volume":"35","author":"Sela","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.redox.2024.103457_bib58","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1021\/acsnano.1c08120","article-title":"Smart nanomedicine to enable crossing blood\u2013brain barrier delivery of checkpoint blockade antibody for immunotherapy of glioma","volume":"16","author":"Wang","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.redox.2024.103457_bib59","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s12272-021-01341-7","article-title":"Methamphetamine-induced dopaminergic neurotoxicity as a model of Parkinson's disease","volume":"44","author":"Shin","year":"2021","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.redox.2024.103457_bib60","article-title":"Methamphetamine and Parkinson's disease, park","volume":"2013","author":"Granado","year":"2013","journal-title":"Dis"},{"key":"10.1016\/j.redox.2024.103457_bib61","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s12272-023-01467-w","article-title":"Exploring new histone deacetylase 6 inhibitors and their effects on reversing the \u03b1-tubulin deacetylation and cell morphology changes caused by methamphetamine","volume":"46","author":"Gupta","year":"2023","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.redox.2024.103457_bib62","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.toxlet.2015.02.011","article-title":"Methamphetamine promotes \u03b1-tubulin deacetylation in endothelial cells: the protective role of acetyl-l-carnitine","volume":"234","author":"Fernandes","year":"2015","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.redox.2024.103457_bib63","doi-asserted-by":"crossref","first-page":"10842","DOI":"10.1021\/ja102758v","article-title":"Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, Tubastatin A","volume":"132","author":"V Butler","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.redox.2024.103457_bib64","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1073\/pnas.0430973100","article-title":"Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation","volume":"100","author":"Haggarty","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.redox.2024.103457_bib65","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1021\/jm8002894","article-title":"Use of the nitrile oxide cycloaddition (NOC) reaction for molecular probe generation: a new class of enzyme selective histone deacetylase inhibitors (HDACIs) showing picomolar activity at HDAC6","volume":"51","author":"Kozikowski","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.redox.2024.103457_bib66","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.toxlet.2019.11.028","article-title":"The effect of \u03b1-synuclein and Tau in methamphetamine induced neurotoxicity in vivo and in vitro","volume":"319","author":"Ding","year":"2020","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.redox.2024.103457_bib67","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1574","article-title":"Effect of Parkin on methamphetamine-induced \u03b1-synuclein degradation dysfunction in vitro and in vivo","volume":"10","author":"Meng","year":"2020","journal-title":"Brain Behav"},{"key":"10.1016\/j.redox.2024.103457_bib68","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1021\/acschemneuro.1c00373","article-title":"Tetrahydropalmatine regulates BDNF through TrkB\/CAM interaction to alleviate the neurotoxicity induced by methamphetamine","volume":"12","author":"Liu","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.redox.2024.103457_bib69","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1021\/acschemneuro.5b00010","article-title":"Increased vesicular monoamine transporter 2 (VMAT2) protects against methamphetamine toxicity","volume":"6","author":"Lohr","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.redox.2024.103457_bib70","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.bbr.2012.04.001","article-title":"Role of oxidative stress in methamphetamine-induced dopaminergic toxicity mediated by protein kinase C\u03b4","volume":"232","author":"Shin","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.redox.2024.103457_bib71","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1007\/s12035-013-8617-1","article-title":"Ginsenoside Re rescues methamphetamine-induced oxidative damage, mitochondrial dysfunction, microglial activation, and dopaminergic degeneration by inhibiting the protein kinase C\u03b4 gene","volume":"49","author":"Shin","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.redox.2024.103457_bib72","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/jpi.12195","article-title":"Liposomal melatonin rescues methamphetamine-elicited mitochondrial burdens, pro-apoptosis, and dopaminergic degeneration through the inhibition PKC\u03b4 gene","volume":"58","author":"Nguyen","year":"2015","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.redox.2024.103457_bib73","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neuro.2015.08.006","article-title":"Characterization of binge-dosed methamphetamine-induced neurotoxicity and neuroinflammation","volume":"50","author":"McConnell","year":"2015","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.redox.2024.103457_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2019.110761","article-title":"Protein kinase C\u03b4 mediates methamphetamine-induced dopaminergic neurotoxicity in mice via activation of microsomal epoxide hydrolase","volume":"133","author":"Shin","year":"2019","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.redox.2024.103457_bib75","article-title":"Parkinson's disease: current status, diagnosis, and treatment using nanomedicines","volume":"6","author":"Hasan","year":"2023","journal-title":"Adv. Ther."},{"key":"10.1016\/j.redox.2024.103457_bib76","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201801362","article-title":"Overcoming the blood\u2013brain barrier: the role of nanomaterials in treating neurological diseases","volume":"30","author":"Furtado","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.redox.2024.103457_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114619","article-title":"Strategies to overcome\/penetrate the BBB for systemic nanoparticle delivery to the brain\/brain tumor","volume":"191","author":"Liu","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.redox.2024.103457_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117917","article-title":"GKT136901 protects primary human brain microvascular endothelial cells against methamphetamine-induced blood-brain barrier dysfunction","volume":"256","author":"Hwang","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.redox.2024.103457_bib79","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/2045-8118-10-33","article-title":"Comparative study of four immortalized human brain capillary endothelial cell lines, hCMEC\/D3, hBMEC, TY10, and BB19, and optimization of culture conditions, for an in vitro blood\u2013brain barrier model for drug permeability studies","volume":"10","author":"Eigenmann","year":"2013","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.redox.2024.103457_bib80","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.biomaterials.2016.06.051","article-title":"In vitro screening of nanomedicines through the blood brain barrier: a critical review","volume":"103","author":"Aparicio-Blanco","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.redox.2024.103457_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113591","article-title":"Methamphetamine induced neurotoxic diseases, molecular mechanism, and current treatment strategies","volume":"154","author":"Shrestha","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.redox.2024.103457_bib82","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1039\/C7TX00189D","article-title":"Role of GSK3\u03b2\/\u03b1-synuclein axis in methamphetamine-induced neurotoxicity in PC12 cells","volume":"7","author":"Li","year":"2018","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.redox.2024.103457_bib83","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.brainres.2019.05.035","article-title":"Methamphetamine persistently increases alpha-synuclein and suppresses gene promoter methylation within striatal neurons","volume":"1719","author":"Biagioni","year":"2019","journal-title":"Brain Res."},{"key":"10.1016\/j.redox.2024.103457_bib84","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s12640-021-00332-2","article-title":"The role of \u03b1-synuclein in methamphetamine-induced neurotoxicity","volume":"39","author":"Wu","year":"2021","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.redox.2024.103457_bib85","article-title":"A novel nanoparticle system targeting damaged mitochondria for the treatment of Parkinson's disease, Biomater","volume":"138","author":"Chen","year":"2022","journal-title":"Adv"},{"key":"10.1016\/j.redox.2024.103457_bib86","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/JPD-201981","article-title":"Mitochondria and Parkinson's disease: clinical, molecular, and translational aspects","volume":"11","author":"Borsche","year":"2021","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.redox.2024.103457_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2022.04.003","article-title":"Enhancement of blood\u2013brain barrier penetration and the neuroprotective effect of resveratrol","volume":"346","author":"Katila","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.redox.2024.103457_bib88","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1021\/acscentsci.2c00741","article-title":"Brain-targeted biomimetic nanodecoys with neuroprotective effects for precise therapy of Parkinson's disease","volume":"8","author":"Liu","year":"2022","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.redox.2024.103457_bib89","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.13056","article-title":"Glial activation in prion diseases is selectively triggered by neuronal PrPSc","volume":"32","author":"Lakkaraju","year":"2022","journal-title":"Brain Pathol."},{"key":"10.1016\/j.redox.2024.103457_bib90","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1038\/s41467-023-39060-w","article-title":"Border-associated macrophages mediate the neuroinflammatory response in an alpha-synuclein model of Parkinson disease","volume":"14","author":"Schonhoff","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.redox.2024.103457_bib91","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202007765","article-title":"Multiple protective roles of nanoliposome-incorporated baicalein against alpha-synuclein aggregates","volume":"31","author":"Aliakbari","year":"2021","journal-title":"Adv. Funct. Mater."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221323172400435X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221323172400435X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T03:26:43Z","timestamp":1736738803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221323172400435X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":91,"alternative-id":["S221323172400435X"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2024.103457","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HDAC6 inhibitor-loaded brain-targeted nanocarrier-mediated neuroprotection in methamphetamine-driven Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2024.103457","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103457"}}